Related by context. All words. (Click for frequent words.) 60 Monoclonal Antibodies 60 Asthma COPD 58 Benign Prostatic Hyperplasia 57 Neuroprotection 57 Neurodegenerative 57 Alzheimer disease cognitive impairment 57 Mimetics 56 Neuropathic Pain 56 neuronal nicotinic receptors NNRs 56 Anti infective 56 Mouse Model 56 Therapeutic Targets 56 Smooth Muscle 56 Cognitive Deficits 56 Therapeutic Antibodies 55 Novel Therapies 55 Therapeutic Approaches 55 inflammatory demyelinating 55 inflammatory autoimmune 55 Small Molecule 55 Metabolic Disease 55 Tumor Targeting 55 Anti Infectives 55 Allergic Rhinitis 55 endocrine diseases 55 Inflammatory Disease 55 CNS disorders 55 Genes Involved 55 Drug Pipeline 55 Antisense Drug 55 Breast Cancer Metastasis 55 Drug Discovery 55 Novel Treatments 55 thetreatment 55 Novel Therapeutics 54 Inflammatory Diseases 54 cardiovascular metabolic 54 Receptor Agonist 54 JAK2 Inhibitor 54 Novel Oral 54 Davunetide 54 Preclinical Development 54 Transdermal Patch 54 Safinamide 54 Autoimmune Disease 54 Drug Candidate 54 Muscle Wasting 54 Cancer Vaccines 54 Cardiometabolic 54 G Protein Coupled 54 epilepsy multiple sclerosis 54 Therapeutic Potential 54 Stakeholder Opinions 54 Prolongs Survival 54 Pulmonary Arterial Hypertension 54 RNAi Therapeutics 53 Detrol Detrol LA 53 Patients Suffering 53 Savella TM 53 Supernus Pharmaceuticals 53 Therapeutic Antibody 53 Iron Overload 53 degenerative disorders 53 Epilepsy Drug 53 Chemokine Receptor 53 epilepsy Parkinson disease 53 Shows Promise Against 53 Immune Mediated 53 Drug Shows Promise 53 neuropathic pain 53 Drug Delivery 53 Aurora Kinase 53 Synthetic Peptide 53 Ion Channels 53 Nucleic Acids 53 Slow Progression 53 Slows Progression 53 Fabry Disease 53 Receptors GPCRs 53 Parkinson Disease PD 53 Clinical Outcome 53 Epidermal Growth Factor Receptor 53 Immune Cell 53 Hepatocellular Carcinoma 53 Protein Kinase C 53 Protein Therapeutics 53 opioid induced 53 Novel Therapeutic 53 CNS Therapeutics 53 Effectively Treats 53 Neuropathic pain 53 Initiates Clinical Trial 53 immuno inflammatory diseases 53 Systemic lupus erythematosus SLE 53 Bucindolol 53 tiapamil 53 Drug Metabolism 53 Dendritic Cells 53 neuropathic pain metabolic diseases 53 infectious autoimmune 53 Glycosylation 53 Ropinirole 52 Archexin 52 Demyelinating 52 Autoimmune 52 Initiates Dosing 52 Innate Immune 52 therapeutics 52 Present Preclinical Data 52 RNAi Therapeutic 52 Myelofibrosis 52 Theranostics 52 Leber Hereditary Optic Neuropathy 52 Trodusquemine MSI 52 norepinephrine reuptake inhibitor 52 Anti Angiogenesis 52 diarrhea predominant irritable 52 Inflammatory Bowel Disease 52 Fibromyalgia Syndrome FMS 52 Inflammatory Arthritis 52 inflammatory disorders 52 Immunotherapeutic 52 Neurodegenerative Disease 52 kidney urologic 52 multiple sclerosis Parkinson disease 52 Brodmann Area 52 Chemotherapy induced 52 autoimmune inflammatory 52 circadian rhythm sleep 52 Kinase Inhibitors 52 Nerve Targeting Drug 52 PDE inhibitors 52 Squalamine 52 Overactive Bladder 52 NNRs 52 Transdermal Drug 52 Nuclear Receptors 52 Recombinant Protein 52 FOLOTYN ® 52 Treatment Approaches 52 protein tyrosine phosphatases 52 Ischemic Spastic Paraplegia Traumatic 52 Anti Tumor 52 PLX MS 52 hypertension osteoarthritis 52 Antisense 52 Novel Small Molecule 52 Milnacipran 52 Signal Transduction 52 Oncology Drug 52 Autoimmune Diseases 52 Files IND 52 Targeted Therapies 52 Orphan Diseases 51 Maven Semantic 51 Shows Efficacy 51 oncology infectious diseases 51 rheumatoid arthritis Crohn disease 51 Phase IIb Clinical Trial 51 Neurodegeneration 51 mGluR2 NAM 51 Genes Linked 51 Factor NGF 51 Tasimelteon 51 Enkephalin 51 chronic thromboembolic pulmonary 51 rare autosomal recessive 51 Gout Drug 51 Kinase Inhibitor 51 Therapeutic Monoclonal Antibodies 51 SYN# 51 CNS gastrointestinal GI 51 polyneuropathy HIV DSP 51 PDE# 51 Biosimilar 51 PDE# inhibitors 51 Subtypes 51 Generalized Anxiety Disorder 51 Transdermal Delivery 51 Alzheimer Disease Parkinson Disease 51 Neurological Diseases 51 Daclizumab 51 Recombinant Human 51 myelofibrosis polycythemia vera 51 Friedreich Ataxia FRDA 51 5 HT6 receptor 51 Antiplatelet 51 Eli Lilly Cymbalta 51 MTP inhibitor 51 lupus multiple sclerosis 51 neuropsychiatric diseases 51 Pimavanserin 51 Rheumatoid Arthritis 51 Frontotemporal Dementia 51 Genetic Variation 51 Therapeutic Agents 51 ERYtech 51 Clinical Trial Results 51 Aviptadil 51 Interferon Beta 51 Psoriatic arthritis 51 IL# PE#QQR 51 Generic Versions 51 Rheumatoid Arthritis RA 51 Psoriasis Drug 51 Antipsychotic 51 Monoclonal Antibody 51 Extracellular Matrix 51 Dyskinesia 51 erythematosus 51 Myelodysplastic Syndromes 51 oncology immunology 51 cognitive dysfunctions 51 Enzyme Replacement Therapy 51 Anti Angiogenic 51 Mitochondrial Dysfunction 51 Initiates Clinical 51 mGlu2 3 51 Muscarinic 51 GI motility disorders 51 Antisocial personality 51 Tyrosine Kinase Inhibitor 51 Novel Antibody 51 Analytical Tool 51 GABITRIL 51 autoimmune diseases inflammation 51 Molecular Mechanism 51 Sustained Release 51 diagnostic molecular imaging 51 Major Depressive Disorder MDD 51 Pregabalin 51 Brain Plasticity 51 Mouse Models 51 neuropathic pain spasticity 51 Natalizumab 51 Patient Enrollment 51 Synthetic Chemistry 51 Phase 2b Clinical Trial 51 pralatrexate injection folate analogue 51 Parkinson disease Alzheimer disease 50 Female Sexual Arousal 50 Cytotoxic 50 selective modulator 50 Cancer Stem Cells 50 investigational compounds 50 ropinirole Requip 50 Angiogenic 50 Radiopharmaceutical 50 siRNA Delivery 50 Metabolic Disorders 50 Vascular Targeting Agents 50 Serdolect ® 50 Personalised Medicine 50 pathological hallmarks 50 Iloperidone 50 protein kinase inhibitors 50 XIAFLEX ® 50 Pirfenidone 50 Genetic Marker 50 histone deacetylase 50 Anthrax Toxin 50 milnacipran HCl 50 TNF Tumor Necrosis Factor 50 tPEMF tm 50 Diabetic Neuropathic Pain 50 ocular inflammatory 50 respiratory gastrointestinal 50 Rotigotine 50 norepinephrine reuptake inhibitor SNRI 50 Novel Antibiotic 50 Gene Silencing 50 Chemokine 50 Topical Treatment 50 neuro inflammatory 50 Therapeutic Competitors Companies 50 injury ischemic spastic 50 Cognitive Disorders 50 asthma COPD Chronic 50 potential vanilloid 50 Chronic Inflammation 50 Pathogenesis 50 progressive neurodegenerative 50 REMOXY R 50 Ocrelizumab 50 Galantamine 50 renal diseases 50 Excretion 50 Neurodegenerative diseases 50 Diabetic neuropathy 50 musculoskeletal diseases 50 cognitive impairment associated 50 Osteoporosis Treatment 50 Protein Involved 50 Anticoagulant 50 arthritis cardiovascular disease 50 SAR# [002] 50 Vitro Diagnostics 50 TÎ ² 4 50 Milestone Payment 50 Rheumatoid Arthritis Drug 50 Antibacterials 50 Systemic Delivery 50 Sapacitabine 50 Liver Toxicity 50 engineered RAP peptides 50 Catena ® 50 Anticonvulsants 50 Liver Injury 50 Nicotine Vaccine 50 Respiratory Virus 50 Lyrica pregabalin 50 postherpetic neuralgia PHN painful 50 neuroprotection 50 Ceflatonin R 50 targeted radiotherapeutic 50 Marillion Pharmaceuticals 50 Angiogenesis 50 Receives Orphan Drug Designation 50 NTDDS 50 HIV distal sensory 50 metabotropic glutamate receptors 50 Viral Infections 50 Shown Effective 50 Cerebellar 50 Protein Kinase 50 Protein Expression 49 Frozen Shoulder Syndrome 49 constipation predominant irritable bowel 49 cardio metabolic diseases 49 constipation OIC 49 Virus Linked 49 Multiple sclerosis MS 49 osteoarthritis rheumatoid arthritis 49 Logical Therapeutics 49 dermatological disorders 49 immuno inflammatory 49 autoimmune diseases inflammatory 49 Polyneuropathy 49 New Chemical Entities 49 fibromyalgia syndrome 49 Phase 2a Trial 49 Hematological 49 protein misfolding diseases 49 Microplasmin 49 Etanercept 49 molecular imaging radiopharmaceutical 49 Hepatitis C Virus 49 debilitating autoimmune 49 Hematological Malignancies 49 post herpetic 49 fibrotic diseases 49 neuropathy nerve 49 CB1 antagonists 49 Nuron Biotech 49 rheumatoid arthritis juvenile idiopathic 49 Novel Approaches 49 Lowers Risk 49 aMCI precursor 49 FDA Anti Infective 49 Exploratory Clinical 49 opioid receptor antagonist 49 TTR amyloidosis 49 Signal Transducers 49 targeted radiotherapeutics 49 mGluR2 49 Cethrin R 49 Lung Cancer Drug 49 Liprotamase 49 Interferon beta 49 immunologic diseases 49 Pulmonary Drug 49 Pulmonary Hypertension 49 VentiRx Pharmaceuticals 49 Hsp# Inhibitor 49 5EU 49 Carbidopa 49 venomics 49 CB2 receptor 49 Postdoctoral Position 49 immuno modulatory 49 Inflammatory bowel diseases 49 Digestive Tract 49 diagnostic biomarkers 49 Cannabinoid 49 Alvine Pharmaceuticals 49 Lupus Drug 49 Receives Orphan Drug 49 rheumatoid arthritis multiple sclerosis 49 Biomarker Study 49 P#X# 49 Hemostasis 49 ACV1 49 Biological Therapy 49 Vaccine Adjuvants 49 Targeted Therapy 49 numbness dizziness 49 Anti Infective 49 Icatibant 49 progressive neurodegenerative disorder 49 Tissue Repair 49 immunological diseases 49 disorder OCD 49 Alzheimer disease frontotemporal dementia 49 cannabinor 49 Restless Legs Syndrome RLS 49 Therapeutic Vaccines 49 Cell Transplant 49 Rebif ® 49 Commercialize Novel 49 Preclinical Data 49 Early Diagnosis 49 HP Acthar Gel repository 49 2A receptor agonist 49 Postherpetic neuralgia PHN 49 acne rosacea 49 Neurological Devices 49 Inflammatory Bowel Diseases 49 female sexual arousal 49 neurology immunology 49 post operative ileus 49 Anticancer Agents 49 Veterinary Vaccines 49 antisense inhibitor 48 Small Molecules 48 investigating Serdaxin 48 GW# [003] 48 Campath ® 48 Cimzia ® certolizumab pegol 48 Tß4 48 diseases fat malabsorption 48 Personalized Immunotherapy 48 Autoimmune Disorders 48 Protein Biomarker 48 Lubiprostone 48 treating neuropathic pain 48 Anti Inflammatory 48 Brain Tumor Therapy 48 Antibody Discovery 48 neuromuscular spasm 48 topically delivered 48 Tumor Angiogenesis 48 investigational humanized monoclonal antibody 48 immune modulatory 48 psoriasis rheumatoid arthritis 48 treat gastrointestinal disorders 48 dermatological diseases 48 Creabilis Therapeutics 48 Cancer Therapies 48 Wellstat 48 Cell Adhesion 48 inflammatory diseases 48 gastrointestinal disorders ATI 48 pharmacological chaperone 48 sirtuin therapeutics 48 ophthalmologic disorders 48 Morquio 48 Major Depressive Disorder 48 Antibody Therapeutics 48 vitro pharmacology 48 Qutenza TM 48 RNA Interference 48 Zemiva TM 48 multiple sclerosis rheumatoid arthritis 48 Zenvia ™ 48 Therapeutic Proteins 48 P#X# antagonist 48 oral immunomodulatory 48 beta secretase inhibitors 48 Factor VIIa 48 Insulin Resistance 48 AMD diabetic retinopathy 48 acute mania 48 AZD# TC 48 postoperative ileus 48 Epigenetics 48 hereditary degenerative 48 Aptamer 48 Therapy Shows Promise 48 rxRNA 48 mGluR2 positive 48 multiple sclerosis psoriasis 48 Pathogen Detection 48 myeloproliferative disorders 48 Prodarsan R 48 Jain PharmaBiotech 48 Lewy bodies DLB 48 neuro degenerative diseases 48 neurotherapy 48 Emerging Therapies 48 Autoimmune disorders 48 prokinetic agent 48 Adenoma 48 Omacetaxine 48 POSIDUR TM ELADUR TM 48 J. Donald deBethizy 48 Biopharmaceutical Industry 48 Presents Preclinical Data 48 Neglected Diseases initiative 48 hereditary emphysema 48 A3 adenosine receptor 48 BEMA TM Fentanyl 48 pregabalin Lyrica 48 Poster Presentation 48 GABAA receptors 48 postoperative ileus POI 48 allosteric modulator PAM 48 inherited retinal 48 Lamotrigine 48 EnVivo Pharmaceuticals 48 Renal Cancer 48 identify protein biomarkers 48 Golimumab 48 Diagnosis Treatment 48 nociceptive pain 48 Anticonvulsant 48 Preclinical Evaluation 48 commercializing therapeutic 48 Develop Novel 48 Irritable Bowel Syndrome IBS 48 Bifeprunox 48 obstructive sleep 48 Fewer Side Effects 48 Oligonucleotides 48 overactive bladder syndrome 48 nitric oxide donating prostaglandin 48 therapeutic monoclonal antibodies 48 PharmaVitae Profile 48 synthetic siRNA 48 HIV Integrase 48 selective androgen receptor modulators 48 Resolvyx Pharmaceuticals 48 Pandemic Influenza Vaccines 48 NUVIGIL 48 Mucosal 48 Tapentadol 48 Avanafil 48 cutaneous lupus 48 Huntingtons disease 48 Pharmacogenomic 48 Molecular Mechanisms 48 Cancer Treatments 48 THR beta agonist 48 Adenosine Therapeutics 48 Elagolix 48 neuronal plasticity 48 Novel Vaccine 48 transthyretin TTR mediated amyloidosis 48 Insulins 48 pulmonary arterial hypertension PAH 48 alvimopan 48 Rotavirus Vaccines 48 Clinical 48 Radiation Treatment 48 ELND-#/AZD-# 48 Cell Therapies 48 rivastigmine Exelon 48 Help Predict 48 Innate Immunity 48 tizanidine hydrochloride short 48 Orexin 48 agomelatine 48 Parnate 48 Akebia Therapeutics 47 Panzem R 47 Membrane Protein 47 DNA Methylation 47 Demonstrates Efficacy 47 Firazyr 47 Molecular Basis 47 Ridaforolimus 47 Clofarabine 47 resolvins 47 Nucleic Acid 47 Anidulafungin 47 Metabolic Diseases 47 monoamines 47 Antifungals 47 Tumor Microenvironment 47 BiTE Antibody 47 orally inhaled migraine 47 biologic therapeutics 47 Fingolimod 47 opioid induced bowel dysfunction 47 neurological diseases 47 Cetrorelix 47 Anticancer Agent 47 Spinal cord stimulation 47 neurodegenerative diseases 47 CYT# potent vascular disrupting 47 Carfilzomib 47 Ustekinumab 47 Molecular Diagnostic 47 Gene Expression Analysis 47 novel therapeutic antibodies 47 Tardive Dyskinesia 47 Stem Cell Therapies 47 hypothalamic pituitary adrenal axis 47 myoclonus 47 beta interferons 47 rheumatoid arthritis psoriatic arthritis 47 desvenlafaxine 47 oropharyngeal candidiasis 47 melatonin receptors 47 syndrome OSAS 47 DDP# 47 Raptiva R 47 M.D. Ph.D. 47 aripiprazole Abilify 47 R#/MEM 47 symptomatic neurogenic orthostatic hypotension 47 inflammatory cardio metabolic 47 Diabetic Macular Edema 47 Pfizer Lyrica 47 PsychoGenics 47 PI3K/mTOR 47 inflammation thrombosis oncology 47 Janus kinase 47 GSK Oncology 47 tramiprosate 47 Immunochemistry 47 VEGF receptor 47 Cannabinor 47 entitled Compositions 47 psoriasis psoriatic arthritis 47 obstructive sleep apnea hypopnea 47 severe gastroparesis 47 Vaprisol 47 immune modulating 47 thrombotic disorders 47 Protein Interactions 47 TLR antagonists 47 Trandolapril 47 Prove Effective 47 Antitumor 47 gaboxadol 47 acadesine 47 BENLYSTA ® 47 Inflammation 47 investigational therapies 47 neurodegenerative disorders 47 Receptos 47 Autoimmunity 47 neuronal dysfunction 47 lysosomal storage disorder 47 Mirapexin 47 selective inhibition 47 Antiviral Therapeutics 47 Almorexant 47 deacetylase inhibitors 47 Peyronie Disease 47 multiple sclerosis Crohn disease 47 Parkinson disease multiple sclerosis 47 Molecular Cancer 47 GGF2 47 Vantia Therapeutics 47 ESBA# 47 nephropathic cystinosis 47 Archemix Corp. 47 Cogane 47 glaucoma cataract 47 Tolvaptan 47 Biogen Avonex 47 infectious diseases autoimmune diseases 47 KRN# 47 Brussels THR 47 Alemtuzumab 47 antisense inhibitors 47 Cancer Immunotherapy 47 Decision Biomarkers 47 Cancer Biomarkers 47 cardiometabolic 47 XYZAL R 47 Biomarkers 47 Ulcerative Colitis 47 Circ Pharma 47 Phase III Trials 47 bowel dysfunction 47 ALN TTR 47 receptor modulators 47 cMET 47 Myolimus 47 intravenous methylnaltrexone 47 Alzheimer disease Parkinson disease 47 cardiovascular disorders 47 Inhalation Solution 47 Relapsing remitting 47 gastrointestinal GI 47 Entereg TM 47 NNR Therapeutics 47 PsA 47 INS# [001] 47 nicotinic acetylcholine receptor 47 Lennox Gastaut Syndrome 47 Non Invasive 47 Provectus Pharmaceuticals specializes 47 ARRY # 47 Nasdaq HALO biopharmaceutical 47 Ampakine compounds 47 rheumatoid arthritis osteoarthritis ankylosing 47 SIX RO ROG 47 Retrovirus 47 Cognitive Dysfunction 47 rheumatoid arthritis inflammatory bowel 47 Potentially Fatal 47 NeuroTrans TM 47 Multaq dronedarone 47 Parkinson disease epilepsy 47 vascular endothelial dysfunction 47 migraines neurorehabilitation 47 herpes simplex viruses 47 Gastric Cancer 47 Lu AA# 47 relapsing forms 47 IMiDs R 47 beta 1a 47 multitargeted 47 Atypical Antipsychotic 47 tauopathies 47 Patent Covering 47 Pramipexole 47 Reduced Risk 46 ophthalmological diseases 46 nalbuphine ER 46 DermTech International 46 Pharmacodynamics 46 Rasagiline 46 Biomarker 46 Hypoactive Sexual Desire Disorder 46 demyelinating 46 Alnylam Pharma 46 HQK 46 Newly Identified 46 oral prodrug 46 CCR9 antagonist 46 nicotinic alpha 7 46 EGFR HER 46 Pharmacogenomics 46 heterozygous FH 46 vaginal candidiasis 46 Clinical Trials 46 Monoclonal antibody 46 MicroRNA 46 Agios Pharmaceuticals 46 anti epileptics 46 HCV Protease Inhibitor 46 Guanilib 46 NuMimetic TM 46 Sudhir Agrawal D.Phil 46 CYT# novel 46 rufinamide 46 Metabolic Profiling 46 headache nausea dizziness 46 Efficacy Trial 46 painful diabetic neuropathy 46 rheumatoid arthritis psoriasis Crohn 46 Neuroscience 46 endophenotypes 46 Proprietary Products 46 AA Amyloidosis 46 HeFH 46 thrombotic diseases 46 Prostate Cancer Treatment 46 excessive underarm sweating 46 Hutchinson Gilford progeria 46 neuropathies 46 ceroid lipofuscinosis NCL 46 Novel Drug 46 skeletal muscle weakness 46 Neurotherapeutics 46 Relieves Pain 46 macular degeneration diabetic retinopathy 46 diabetic peripheral neuropathic pain 46 purinergic receptors P#X# 46 Preclinical 46 neurologic diseases 46 Panzem 46 Surface Modification 46 circadian rhythm disorders 46 arterial thrombosis 46 benign prostatic hypertrophy BPH 46 Preclinical Study 46 Age Related Macular 46 enhance ApoA 46 Entereg R 46 molecular biomarkers 46 neurological disorder characterized 46 Restless Legs Syndrome 46 Lixivaptan 46 vertigo dizziness 46 depressive episodes associated 46 anti amnesic 46 AT1R 46 Prozac fluoxetine 46 Not Otherwise Specified 46 LHON 46 systemic juvenile idiopathic 46 Circulatory 46 Protein Interaction 46 XEN# 46 commercialize microRNA 46 diabetic neuropathic pain 46 Clinical Trial 46 Epiphany Biosciences 46 cardio renal 46 intracellular signaling pathways 46 neuroinflammatory 46 Help Detect 46 chemotherapy induced neutropenia 46 PDE4 modulators 46 novel anti infective 46 SGLT2 inhibitors 46 Preclinical Clinical 46 ZEVALIN ® 46 primary dysmenorrhea 46 Vaccine Adjuvant 46 Enbrel Humira 46 diabetic peripheral neuropathy 46 Flow Cytometry 46 leukoencephalopathy PML 46 Molecular Pathogenesis 46 Pervasive Developmental Disorders 46 NASDAQ BTRX pharmaceutical 46 Allosteric 46 NeurAxon Inc. 46 intranasal delivery 46 novel antibody therapeutics 46 rheumatoid arthritis psoriasis 46 Valdoxan 46 Collaborators Publish 46 Soliris eculizumab 46 Protein Structure 46 ankylosing spondylitis AS 46 novel peptides 46 neurogenic 46 adenosine A2A 46 Therapeutic Vaccine 46 Murine Model 46 diabetic peripheral neuropathic DPN 46 gastrointestinal GI motility disorders 46 Therapeutic Protein 46 peripherally acting 46 Neovascular AMD 46 Antibiotic Resistant 46 Anti Diabetic 46 mertansine 46 PKU genetic 46 anticancer therapeutics 46 macular degeneration glaucoma 46 autoimmune encephalitis 46 gastrointestinal motility 46 Human Monoclonal Antibodies 46 constipation IBS C 46 CB2 selective receptor agonist 46 RNAi therapeutic targeting 46 Juvenile Idiopathic Arthritis 46 chronic opioid 46 immunotherapy treatments 46 TLR9 agonists 46 Carbamazepine 46 ibudilast 46 small molecule therapeutics 46 neuro protective 46 Smac mimetics 46 CEQ# 46 NMDA Receptor 46 Nanoemulsion 46 adalimumab Humira 46 Phase IIb clinical trials 46 INVEGA ® 46 Regenerative medicine 46 Aricept donepezil 46 Entry Inhibitor 46 ophthalmic diseases 46 Janus Kinase 46 LEVADEX TM 46 R#/MEM # 46 Genedata Expressionist ® 46 DepoDur 46 SNT MC# 46 FoldRx Pharmaceuticals Inc. 46 ANG# 46 Duloxetine 46 IAP inhibitor 46 quinidine sulfate 46 degenerative neurological diseases 46 primary Restless Legs 46 YONDELIS 46 medically refractory 46 Conatus Pharmaceuticals 46 receptor partial agonist 46 Locus Pharmaceuticals 46 vinca alkaloid 46 ankylosing spondylitis psoriatic arthritis 46 PDUFA Date 46 Peripheral neuropathy 46 neurogenic bladder 46 neuroinflammatory diseases 46 markets Gelclair R 46 Neural Circuits 46 sodium thiosulfate STS 46 Treat Parkinson Disease 46 Antiviral Drugs 46 dermatology therapies 46 Anticancer Drug 46 Oligonucleotide 46 neuronal nicotinic receptor NNR 46 Cenomed 46 glaucoma macular degeneration 46 peptide therapeutics 46 Biochip 46 Ostabolin C TM 46 epigenetic enzymes 46 overactive bladder symptoms 46 venous stasis ulcers 46 Exp Clin 46 microtubule inhibitor 46 cardiometabolic disorders 46 tetrabenazine 46 Zingo TM 45 Psychosocial Factors 45 epilepsies 45 Immunex Corporation 45 Nuvigil armodafinil 45 Drug Repositioning 45 Amira Pharmaceuticals 45 renal anemia 45 agonists antagonists 45 serotonin dopamine 45 small molecule agonists 45 Xanthus Pharmaceuticals Inc. 45 hyperprolactinemia 45 depression schizophrenia bipolar 45 Alzheimer Disease AD 45 oligonucleotide therapeutics 45 Solid Tumor 45 serotonin receptor 45 Desvenlafaxine 45 PKC# 45 ECTRIMS 45 Pediatric Psychopharmacology 45 Bladder Cancer 45 Tranzyme Pharma 45 myeloproliferative diseases 45 Alzheimer disease epilepsy 45 Homspera TM 45 Urine Test 45 NP2 Enkephalin 45 Idera Pharmaceuticals 45 EHT AGN 45 PEGylated interferon beta 1a 45 myeloproliferative neoplasms 45 anti infectives 45 Fragment Based 45 neuroprotective agent 45 Mipomersen 45 Arterial Disease 45 CB2 receptor selective 45 Cx# [002] 45 RECOTHROM R 45 Psychoactive 45 tapentadol 45 PRIALT 45 Disorder ADHD 45 NMDA antagonist 45 Sodium Injection 45 epigenetic therapies 45 insomnia sleep apnea 45 post menopausal osteoporosis 45 Hemostat 45 Oracea TM 45 SGLT Inhibitors 45 Genetic Testing 45 NAGS deficiency 45 Parkinson disease psychosis 45 quetiapine fumarate 45 tuberous sclerosis TS 45 neurological disorder affecting 45 cytomegalovirus CMV HAE 45 bioactive lipids 45 serotonin norepinephrine reuptake inhibitor 45 neuro degenerative disorders 45 efalizumab 45 neuropathic nerve 45 excessive sleepiness associated 45 Spiegelmers R 45 Abiraterone acetate 45 Friedreich Ataxia 45 immune mediated 45 myasthenia gravis Huntington 45 Preclinical Studies 45 Corlux 45 dopamine antagonists 45 adrenal hormones 45 multiple sclerosis cerebral palsy 45 REMOXY ® 45 partial agonist 45 Diagnostic Tests 45 humanized monoclonal 45 Androxal TM